Judge Denies Class Cert. In Cymbalta Withdrawal Risks Suit
A California federal judge has denied class certification in a suit alleging that Eli Lilly & Co. downplayed the withdrawal risks of its antidepressant drug Cymbalta, saying that the plaintiffs' damages...To view the full article, register now.
Already a subscriber? Click here to view full article